EPV004/#360 Inhibition of cancer cell-dependent glycolysis through AVB-500, a selective inhibitor of gas6-axl, in combination with paclitaxel in high-grade endometrial cancer
EPV004/#360 Inhibition of cancer cell-dependent glycolysis through AVB-500, a selective inhibitor of gas6-axl, in combination with paclitaxel in high-grade endometrial cancer